R2 Technologies Receives Final Tranche of $30M Investment to Launch Revolutionary Glacial Rx™ and Glacial Spa™ Aesthetic Skin Treatments
R2 Technologies Receives Final Tranche of $30M Investment to Launch Revolutionary Glacial Rx™ and Glacial Spa™ Aesthetic Skin Treatments News provided by Share this article Share this article SAN RAMON, Calif., Feb. 3, 2021 /PRNewswire/ -- R2 Technologies Inc. ("R2") has received $10 million in funding from Huadong Medicine Company Limited ("Huadong") as the third and final tranche of Huadongs $30 million Series B equity investment. R2s post-money valuation is $113 million which is a prede...
Source: prnewswire.com